Roman Butler Fullerton & CO Novartis Ag Transaction History
Roman Butler Fullerton & CO
- $342 Million
- Q4 2024
A detailed history of Roman Butler Fullerton & CO transactions in Novartis Ag stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 2,248 shares of NVS stock, worth $242,132. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,248Holding current value
$242,132% of portfolio
0.06%Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,448Shares Held
130MCall Options Held
999KPut Options Held
1.32M-
Dodge & Cox San Francisco, CA12.2MShares$1.32 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.19 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$881 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.98MShares$752 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.58MShares$601 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $232B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...